Joseph Hagan
Chief Executive Officer bei REGULUS THERAPEUTICS INC.
Vermögen: 224 407 $ am 31.03.2024
Profil
Joseph P.
Hagan is the founder of GroundSwell Advisors LLC, which was founded in 2008.
He held the title of Partner in the firm in 2009.
Mr. Hagan is currently the Chief Executive Officer & Director at Regulus Therapeutics, Inc., starting in 2016.
Mr. Hagan has held former positions as the Acting Chief Executive Officer at Unity Pharma, Director at Avidia, Inc., Director at ISB Accelerator Corp., Director at Ren Pharmaceuticals, Inc., Managing Director at Amgen Ventures LLC from 1998 to 2008, Director at Accelerator Services Corp, Director at Seredigm Corp., Independent Director at Zosano Pharma Corp.
from 2015 to 2022, Independent Director at Aurinia Pharmaceuticals, Inc. from 2018 to 2023, and Head-Corporate Development at Amgen, Inc. from 1998 to 2008.
He also served as the Chief Financial & Business Officer, Executive VP at Orexigen Therapeutics, Inc. from 2009 to 2015.
Mr. Hagan obtained an MBA from Northeastern University in 1998 and an undergraduate degree from the University of California San Diego in 1992.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.01.2024 | 57 112 ( 0,09% ) | 164 483 $ | 31.03.2024 | |
| 23.05.2023 | 11 961 ( 0,01% ) | 59 925 $ | 31.03.2024 |
Aktive Positionen von Joseph Hagan
| Unternehmen | Position | Beginn |
|---|---|---|
| REGULUS THERAPEUTICS INC. | Chief Executive Officer | 04.05.2017 |
Ehemalige bekannte Positionen von Joseph Hagan
| Unternehmen | Position | Ende |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Director/Board Member | 29.06.2023 |
| ZOSANO PHARMA CORPORATION | Director/Board Member | 10.05.2022 |
| OREXIGEN THERAPEUTICS, INC. | Director of Finance/CFO | 01.12.2015 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Director/Board Member | 30.10.2009 |
| GroundSwell Advisors LLC | Founder | 01.05.2009 |
Ausbildung von Joseph Hagan
| Northeastern University | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| REGULUS THERAPEUTICS INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Avidia, Inc.
 Avidia, Inc. Pharmaceuticals: MajorHealth Technology Avidia, Inc. developed pharmaceutical products. The company developed a novel, proprietary class of small therapeutic proteins. The company was headquartered in Mountain View, CA. | Health Technology |
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services ISB Accelerator Corp. is involved in the study of biological systems to help identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The company is located in Seattle, WA. | Commercial Services |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Health Technology |
Amgen Ventures LLC
 Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Finance |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Seredigm Corp.
 Seredigm Corp. Pharmaceuticals: GenericHealth Technology Seredigm Corp. develops and supplies drugs that protect against tissue damage in acute and chronic medical conditions. The company was founded by John M. Harlan and Robert K. Winn in 2006 and is headquartered in Seattle, WA | Health Technology |
| Unity Pharma | |
| GroundSwell Advisors LLC | |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
